Cargando…
Mandatory Research Biopsy Requirements Delay Initiation of Clinical Trials
Background: There has been an increasing requirement for fresh tumor tissue to enroll in clinical trials in order to look for specific biomarkers. This has been shown to increase screening duration and increase screen failure rates. It was important to corroborate these results in other centers. Met...
Autores principales: | Cheng, Jonathan H., Tiulim, Justin W., Zhou, Sheng, El-Khoueiry, Anthony, Nieva, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813196/ https://www.ncbi.nlm.nih.gov/pubmed/31681560 http://dx.doi.org/10.3389/fonc.2019.00968 |
Ejemplares similares
-
Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
por: Cheng, Xueqing, et al.
Publicado: (2021) -
Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
por: Malewski, Wojciech, et al.
Publicado: (2023) -
Central Counterparties: Mandatory Central Clearing and Initial Margin Requirements for OTC Derivatives
por: Gregory, Jon
Publicado: (2014) -
Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients
por: Chen, Yong-He, et al.
Publicado: (2021) -
Giant retroperitoneal ancient schwannoma: Is preoperative biopsy always mandatory?
por: Al Skaini, Mohammad Saad, et al.
Publicado: (2014)